Accuryn was shown to be significantly superior to BARD CRITICORE in the burn unit setting with hourly urine output monitoring in multicenter randomized controlled study (RCT-ClinicalTrials.gov Identifier: NCT02195713).
The chart below shows a characteristic comparison of urine output over time in a patient using the standard of care device and one using Accuryn.
The impact of airlock reduction on effective continuous urine output was pronounced and found to be statistically significant over the entire study population for:
- No airlocks (p<0.001)
- No periods of false oliguria (p<0.05) in test patients
- No periods of false anuria (p<0.05) in test patients